Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 07, 2019
ANI Pharmaceuticals announced its partner Pii has received FDA approval of a Prior Approval Supplement for Bretylium Tosylate Injection.
read more
Anixa Biosciences has established a strategic alliance and license agreement with Cleveland Clinic for breast cancer vaccine technology.
read more
Thursday, October 31, 2013
Quality by Design (QbD) and its systematic approach to development begins with a predefined objective and emphasizes sound science and quality risk principles as an integral part of product development and process control implementation, and can help...
read more
Friday, February 22, 2013
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the company has formed the Aptuit Scientific Advisory Board (SAB) comprised of scientific experts from within the company. The SAB will regularly meet to assess ...
read more
Monday, November 12, 2012
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the number of clients placing work at The Aptuit Center for Drug Discovery & Development in Verona, Italy has reached 100, giving the site a strong vote of confidence...
read more
Aptuit LLC announced that the company has innovated a translational strategy that represents a unique approach, known as “Complementary Vision,” for those in search of high value Chemistry, Manufacturing and Control (CMC) services.
read more
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the company has launched an interactive link, “Ask an Expert,” on its website to provide informational support to the pharmaceutical community.
read more
Aptuit LLC announces the appointment of two new members to its Executive Leadership team. Kurt Dinkelacker has been named Executive Vice President and Chief Financial Officer and Kevin Duffield has been promoted to Vice President, Sales and Business ...
read more
Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and Marketing, making him responsible for all of Aptuit's sales and marketing activities.
read more
Wednesday, December 04, 2013
Timothy C. Tyson, Chairman of Aptuit LLC, announced today the appointment of Jonathan Goldman, MD as Chief Executive Officer (CEO), completing the company’s senior management leadership team.
read more
Ardena has acquired ChemConnection, a contract manufacturer of novel APIs and nanomedicines.
read more
Ardena has acquired Syntagon, a contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.
read more
Tuesday, November 19, 2024
Ardena announced the full Good Manufacturing Practice (GMP) approval of its expanded nanomedicine facility in Oss, Netherlands.
read more
Thursday, January 02, 2020
Arena Pharmaceuticals and Beacon Discovery have entered into a strategic multi-year partnership aimed at building novel medicines across a range of GPCR targets.
read more
Artelo Biosciences has expanded its existing research and worldwide commercial license agreement with The Research Foundation For The State University of New York, Stony Brook.
read more